Prevalence of lung tumors in patients with esophageal squamous cell carcinoma and vice versa: a systematic review and meta-analysis.

Laurelle van TilburgSteffi E M van de VenManon C W SpaanderLaurens A van KleefRobin CornelissenMarco J BrunoArjun D Koch

Published in: Journal of cancer research and clinical oncology (2022)

Patients with ESCC and LC have an increased risk of developing SPTs in the lungs and esophagus. However, the relatively low SPT prevalence rates do not justify screening in these patients. Further research should focus on risk stratification to identify subgroups of patients at highest risk of SPT development.

Keyphrases

end stage renal disease
risk factors
newly diagnosed
chronic kidney disease
prognostic factors
mass spectrometry
simultaneous determination
patient reported
high resolution mass spectrometry